SCR-LIP-000760 · Claim · machine-readable JSON →
Genetic findings in lipedema include variants and loci in hormone-related pathways, notably steroid hormone metabolism.
General proposition consolidated from 6 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 6 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (6)
- Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema — Michelini et al. (2020) ✓ verified — consistent · case report · 2020 · reading confidence: high
“Variante AKR1C1 c.638T>A; p.L213Q identificada exclusivamente nas 3 pacientes afetadas e ausente nos 9 membros não afetados da família Sanger sequencing confirmou segregação perfeita com o fenótipo lipedema”
Exome sequencing: AKR1C1 p.L213Q segregated with lipedema in 3 affected family members (puberty onset in all), absent in 9 unaffected; predicted partial loss of 20α-HSD function reducing progesterone catabolism.
The article reports a hereditary (autosomal dominant) gene variant segregating with lipedema and links a hormonal mechanism (progesterone metabolism via 20α-HSD) to disease onset at puberty, directly supporting both heredity and hormonal in - From rare familial mutations to multifactorial disease: aldo-keto reductase 1C enzymes as a central biological pathway in lipedema — Vainberg et al. (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“Variante AKR1C1 p.Leu213Gln (L213Q) — descrita por Michelini et al. — segrega com lipedema em 3 gerações”
Review proposes AKR1C1-4 enzymes as a pathway linking rare familial mutations and common regulatory polymorphisms to lipedema via altered steroid hormone metabolism in gluteofemoral adipose tissue.
Review articulating a gene-environment model in which both heredity (familial AKR1C mutations and regulatory polymorphisms) and hormones (steroid metabolism, endocrine disruptors) influence lipedema onset, directly supporting the question's - Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — contextual · review · 2023 · reading confidence: high
“Incidência familiar em 15% de familiares femininas de primeiro grau (herança X-linked dominante ou autossômica dominante com penetrância incompleta, possivelmente oligogênica)”
Review cites the AKR1C1 missense variant (progesterone metabolism) as the first mutated gene in a family with primary non-syndromic lipedema.
The review explicitly documents familial inheritance patterns and a hormone-metabolism gene (AKR1C1, progesterone pathway) variant linked to lipedema, directly bearing on the role of heredity and hormones in onset. [grade capped moderate->very_low per curated Oxford N6] - Lipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“mutação em AKR1C1 (aldo-ceto redutase que catalisa redução de progesterona em 20α-hidroxiprogesterona) em caso familiar; mutação em PIT1 (fator de transcrição para GH, prolactina, TSH-β) em caso esporádico — ambos corroboram influência hormonal na etiologia”
Review cites AKR1C1 (progesterone) mutation in a familial case and PIT1 (GH, prolactin, TSH-β) mutation in a sporadic case as supporting hormonal influence.
The review synthesizes genetic studies (GWAS, sequencing) showing heritable loci and monogenic mutations in hormone-related genes (AKR1C1 affecting progesterone, PIT1 affecting GH/prolactin/TSH), directly supporting both hereditary and horm [grade capped moderate->very_low per curated Oxford N6] - Genome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors — Klimentidis et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
UK Biobank GWAS of an inferred lipedema phenotype: 18 genome-wide significant loci (SNP heritability ~5.13%), genetic correlations with body fat, leptin and age at menopause.
This genome-wide association study identifies heritable genetic risk loci for a lipedema phenotype, directly supporting a hereditary influence; genetic correlations with leptin and age at menopause also touch on hormonal/endocrine links. Co - Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort — Grigoriadis et al. (2021) ✓ verified — consistent · cross sectional · 2021 · reading confidence: high
“Top SNPs included loci associated with lipoma formation, biosynthesis of hormones and lipid hydroxylation.”
UK Lipoedema GWAS: suggestive top SNPs included loci associated with lipoma formation, hormone biosynthesis and lipid hydroxylation.
The GWAS found only suggestive (not genome-wide significant) loci involving hormone biosynthesis and lipid pathways, plus noted frequent family history, consistent with hereditary and hormonal influences; findings require replication, lower
Context (PECO)
Answers these questions
- Do hormonal factors (puberty, pregnancy, menopause, estrogen) trigger or influence lipedema onset? consistent
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000035